IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.8 EUR
0 (0%)
Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 109 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
IVG had positive earnings in 4 of the past 5 years.
IVG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IVG has a Return On Assets (1.73%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 12.39%, IVG is in the better half of the industry, outperforming 73.39% of the companies in the same industry.
With a Return On Invested Capital value of 4.53%, IVG perfoms like the industry average, outperforming 43.12% of the companies in the same industry.
IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.86%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 61.47% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
The Operating Margin of IVG (5.00%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IVG has grown nicely.
With a Gross Margin value of 16.49%, IVG is not doing good in the industry: 90.83% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
IVG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG's Altman-Z score of 1.77 is in line compared to the rest of the industry. IVG outperforms 41.28% of its industry peers.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
IVG has a worse Debt to FCF ratio (14.82) than 71.56% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of IVG (1.35) is worse than 82.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.27%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 73.39% of its industry peers.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.40, IVG is doing good in the industry, outperforming 78.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
The Revenue has decreased by -7.24% in the past year.
Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.06% on average per year.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.81% on average per year.
The Revenue is expected to grow by 4.30% on average over the next years.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.03, the valuation of IVG can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 83.49% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.17. IVG is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 8.72, which indicates a very decent valuation of IVG.
IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 91.74% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (23.79), we can say IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
IVG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IVG is cheaper than 77.06% of the companies in the same industry.
IVG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IVG is cheaper than 68.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.75 | ||
| EV/EBITDA | 5.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.55, IVG pays a bit more dividend than its industry peers.
IVG's Dividend Yield is comparable with the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
BIT:IVG (1/6/2026, 7:00:00 PM)
18.8
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.10B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (6.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-3.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.03 | ||
| Fwd PE | 8.72 | ||
| P/S | 0.34 | ||
| P/FCF | 12.75 | ||
| P/OCF | 3.96 | ||
| P/B | 1.96 | ||
| P/tB | 9.24 | ||
| EV/EBITDA | 5.57 |
EPS(TTM)1.34
EY7.13%
EPS(NY)2.16
Fwd EY11.47%
FCF(TTM)1.47
FCFY7.84%
OCF(TTM)4.75
OCFY25.28%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.27%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
What is the valuation status for IVG stock?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IVECO GROUP NV?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
How financially healthy is IVECO GROUP NV?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
Can you provide the expected EPS growth for IVG stock?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.